BIOMAT Database Logo BIOMAT Database Logo

Reduced acute rejection and side effects with neoral in liver transplantation. 1998

G Tisone, and G Vennarecci, and F Pisani, and L Baiocchi, and E Mercadante, and G Orlando, and A Anselmo, and C U Casciani
Centro Trapianti d'Organo, Clinica Chirurgica, Università di Roma Tor Vergata, Ospedale S. Eugenio, Italy.

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D008297 Male Males
D011241 Prednisone A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver. Dehydrocortisone,delta-Cortisone,Apo-Prednisone,Cortan,Cortancyl,Cutason,Dacortin,Decortin,Decortisyl,Deltasone,Encorton,Encortone,Enkortolon,Kortancyl,Liquid Pred,Meticorten,Orasone,Panafcort,Panasol,Predni Tablinen,Prednidib,Predniment,Prednison Acsis,Prednison Galen,Prednison Hexal,Pronisone,Rectodelt,Sone,Sterapred,Ultracorten,Winpred,Acsis, Prednison
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006084 Graft Rejection An immune response with both cellular and humoral components, directed against an allogeneic transplant, whose tissue antigens are not compatible with those of the recipient. Transplant Rejection,Rejection, Transplant,Transplantation Rejection,Graft Rejections,Rejection, Graft,Rejection, Transplantation,Rejections, Graft,Rejections, Transplant,Rejections, Transplantation,Transplant Rejections,Transplantation Rejections
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective

Related Publications

G Tisone, and G Vennarecci, and F Pisani, and L Baiocchi, and E Mercadante, and G Orlando, and A Anselmo, and C U Casciani
Reduced acute rejection after liver transplantation with Neoral-based triple immunosuppression.
March 1997, Lancet (London, England),
G Tisone, and G Vennarecci, and F Pisani, and L Baiocchi, and E Mercadante, and G Orlando, and A Anselmo, and C U Casciani
Reduced acute rejection after liver transplantation with Neoral-based double immunosuppression.
August 1998, Transplantation proceedings,
G Tisone, and G Vennarecci, and F Pisani, and L Baiocchi, and E Mercadante, and G Orlando, and A Anselmo, and C U Casciani
Low incidence of acute cellular rejection in liver transplantation with Neoral.
August 1998, Transplantation proceedings,
G Tisone, and G Vennarecci, and F Pisani, and L Baiocchi, and E Mercadante, and G Orlando, and A Anselmo, and C U Casciani
Neoral reduces the incidence of acute rejection after renal transplantation.
August 1998, Transplantation proceedings,
G Tisone, and G Vennarecci, and F Pisani, and L Baiocchi, and E Mercadante, and G Orlando, and A Anselmo, and C U Casciani
Neoral in liver transplantation.
August 1996, Transplantation proceedings,
G Tisone, and G Vennarecci, and F Pisani, and L Baiocchi, and E Mercadante, and G Orlando, and A Anselmo, and C U Casciani
Neoral in liver transplantation.
April 1996, Transplantation proceedings,
G Tisone, and G Vennarecci, and F Pisani, and L Baiocchi, and E Mercadante, and G Orlando, and A Anselmo, and C U Casciani
Neoral therapy in liver transplantation.
August 1996, Transplantation proceedings,
G Tisone, and G Vennarecci, and F Pisani, and L Baiocchi, and E Mercadante, and G Orlando, and A Anselmo, and C U Casciani
Neoral in acute renal transplantation.
July 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
G Tisone, and G Vennarecci, and F Pisani, and L Baiocchi, and E Mercadante, and G Orlando, and A Anselmo, and C U Casciani
[Acute cellular rejection in liver transplantation].
March 2005, Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology,
G Tisone, and G Vennarecci, and F Pisani, and L Baiocchi, and E Mercadante, and G Orlando, and A Anselmo, and C U Casciani
Low incidence of rejection after synchronous pancreas-kidney transplantation with Neoral.
August 1998, Transplantation proceedings,
Copied contents to your clipboard!